Using either normothermia or hypothermia as temperature management strategies following cardiac arrest with spontaneous circulation recovery may produce similar patient outcomes with respect to death and severe disability, according to a science advisory from the American Heart Association (AHA) published in Circulation.
The AHA’s Emergency Cardiovascular Care Committee reviewed data from1861 eligible patients (79.4% men) from the Hypothermia Versus Normothermia After Out-of-Hospital Cardiac Arrest (TT2M; ClinicalTrials.gov Identifier: NCT02908308) clinical trial who spontaneously regained circulatory function following an out-of-hospital cardiac arrest. Study participants underwent random assignment to temperature management with hypothermia (target temperature, 33°C) or normothermia (target temperature, 37°C ) for 28 hours, followed by gradual rewarming to 37°C. A total of 46% of individuals managed with normothermia received active temperature management due to a core temperature that approached 37.5°C.
There was no significance difference in the primary outcome of death between individuals managed with hypothermia and participants measured with normothermia (50% vs 48%; P = .37), the report shows. Moderate to severe disability was not significantly different between the groups (55% for both), and hemodynamically compromising arrhythmias occurred more frequently among individuals managed with hypothermia compared with normothermia (24% vs 16%; P < .001). There were not significant differences between the 2 cohorts for other adverse events.
The writing group confirmed that for unresponsive patients who spontaneously regained circulation following cardiac arrest, maintaining patient temperature at 37.5°C or less is a reasonable and evidence-based strategy. However, the team was unable to determine whether hypothermia management offered any additional benefits compared with normothermia. “In the absence of a clear nonsurvivable catastrophic brain injury resulting from [out-of-hospital cardiac arrest], strictly preventing fever with continuous temperature monitoring, providing comprehensive critical care support, and deploying multimodal evidence-based strategies for neuroprognostication at a minimum of 72 hours after normothermia remain essential for unresponsive post–cardiac arrest adult patients,” according to the researchers.
References:
Perman SM, Bartos JA, Del Rios M, et al. Temperature management for comatose adult survivors of cardiac arrest: a science advisory from the American Heart Association. Circulation. Published online August 16, 2023. doi:10.1161/CIR.0000000000001164